Exploring Adherence to First-Line and Second-Line Immunotherapies in Multiple Sclerosis
نویسندگان
چکیده
منابع مشابه
Association of First-Line and Second-Line Antiretroviral Therapy Adherence
BACKGROUND Adherence to first-line antiretroviral therapy (ART) may be an important indicator of adherence to second-line ART. Evaluating this relationship may be critical to identify patients at high risk for second-line failure, thereby exhausting their treatment options, and to intervene and improve patient outcomes. METHODS Adolescents and adults (n = 436) receiving second-line ART were a...
متن کاملFirst-line and second-line antiretroviral therapy.
January, 2004, administration of measles vaccine was recommended between 12 and 24 months of age, instead of between 12 and 15 months when children have the greatest risk of contracting measles. There is no established system to check vaccination status on entry to the school systems. Strong political and social desire has to be inspired, and vigorous educational campaigns for policy makers and...
متن کاملPediatric multiple sclerosis: Conventional first-line treatment and general management.
Many disease-modifying therapies are currently available for adults with relapsing-remitting multiple sclerosis (MS) but none of them has been tested in pediatric MS in randomized placebo-controlled trials. At present, as suggested by observational studies and experts' guidelines, interferon-β and glatiramer acetate continue to be the standard first-line treatments for pediatric MS. Observation...
متن کاملMultiple sclerosis therapeutic strategies: Use second-line agents as first-line agents when time is of the essence.
M ultiple sclerosis (MS) is a damaging CNS disease. Because the CNS has inherent properties that prevent the damage from manifesting readily (e.g., redundancy, plasticity, repair), often irreversible damage is not appreciated until very late. Pathologically it is apparent that permanent and irreversible damage occurs very early in MS plaque formation. Treatment of the disease course can therefo...
متن کاملFuture immunotherapies in multiple sclerosis.
Immunotherapy of multiple sclerosis (MS) will continue to benefit from an increasing understanding of this disease. This knowledge results in newly defined targets for novel therapies. In this article the development of future immunotherapies will be discussed by classifying the approaches into three main types: (1) antigen-specific therapies; (2) agents with a defined target in pathogenic step...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of MS Care
سال: 2020
ISSN: 1537-2073
DOI: 10.7224/1537-2073.2018-068